Vinamilk, Vietnam’s leading dairy brand, made a significant impact at the Growth Asia Summit 2025 in Singapore by introducing its pioneering 6HMO infant formula. This innovation marks a new era in paediatric nutrition, offering a solution that closely mimics the benefits of breast milk, particularly in a region where exclusive breastfeeding rates are modest.
Vinamilk’s Chief Marketing Officer, Nguyen Quang Tri, highlighted the importance of the 6HMO formula, which includes six human milk oligosaccharides (HMOs) that support infant gut and immune health. This breakthrough is particularly crucial in Vietnam, where 55% of infants are not exclusively breastfed during their first six months. The formula aims to bridge this nutritional gap, especially for working mothers who face challenges balancing work and family commitments.
The company’s efforts have not gone unnoticed. Vinamilk ranks sixth globally for dairy brand value and was recognised as the most valuable food and beverage brand in Southeast Asia by Brand Finance in 2023. It is also the only Vietnamese dairy company featured in the Fortune Southeast Asia 500 ranking 2024.
Vinamilk’s innovation is the result of strategic partnerships with six global nutrition companies, enhancing its scientific capabilities. The 6HMO formula, which includes rare oligosaccharides like difucosyllactose and 3-fucosyllactose, fosters beneficial gut bacteria and protects against pathogens.
Nguyen Quang Tri stated, “Our 6HMO breakthrough not only raises nutritional standards but also helps support parents navigating breastfeeding challenges.” This development signifies Vietnam’s transformation into a nutrition powerhouse, with Vinamilk leading the charge in setting new standards in paediatric care.
“`
